California Public Employees Retirement System’s Avadel Pharmaceuticals AVDL Stock Holding History

California Public Employees Retirement System’s Portfolio AVDL Stock Details AVDL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-117,600	Closed	-$1.06M	–	1680
2021 Q1	$1.06M	Hold	117,600	–	–	﹤0.01%	2449
2020 Q4	$786K	Sell	117,600 -13,425	-10%	-$84K	﹤0.01%	2641
2020 Q3	$660K	Buy	131,025 +8	+0%	+$58	﹤0.01%	2572
2020 Q2	$1.06M	Buy	131,017 +54,017	+70%	+$476K	﹤0.01%	2193
2020 Q1	$611K	Sell	77,000 -6,200	-7%	-$47.6K	﹤0.01%	2296
2019 Q4	$628K	Sell	83,200 -1,300	-2%	-$6.87K	﹤0.01%	2617
2019 Q3	$352K	Hold	84,500	–	–	﹤0.01%	2700
2019 Q2	$244K	Hold	84,500	–	–	﹤0.01%	2842
2019 Q1	$122K	Hold	84,500	–	–	﹤0.01%	3023
2018 Q4	$218K	Sell	84,500 -5,901	-7%	-$20.1K	﹤0.01%	2890
2018 Q3	$397K	Sell	90,401 -10,052	-10%	-$54.3K	﹤0.01%	2766
2018 Q2	$616K	Buy	100,453 +6,815	+7%	+$47.8K	﹤0.01%	2550
2018 Q1	$683K	Buy	93,638 +9,138	+11%	+$80.4K	﹤0.01%	2486
2017 Q4	$693K	Hold	84,500	–	–	﹤0.01%	2510
2017 Q3	$887K	Hold	84,500	–	–	﹤0.01%	2370
2017 Q2	$932K	Hold	84,500	–	–	﹤0.01%	2316
2017 Q1	$818K	Sell	84,500 -3,700	-4%	-$37K	﹤0.01%	2414
2016 Q4	$916K	Sell	88,200 -4,500	-5%	-$49.5K	﹤0.01%	2373
2016 Q3	$1.15M	Sell	92,700 -6,400	-6%	-$83.6K	﹤0.01%	2242
2016 Q2	$1.06M	Sell	99,100 -56,500	-36%	-$602K	﹤0.01%	2290
2016 Q1	$1.72M	Sell	155,600 -15,900	-9%	-$158K	﹤0.01%	1987
2015 Q4	$2.09M	Hold	171,500	–	–	﹤0.01%	1906
2015 Q3	$2.8M	Sell	171,500 -3,674	-2%	-$80.9K	﹤0.01%	1683
2015 Q2	$3.71M	Buy	175,174 +45,500	+35%	+$816K	0.01%	1588
2015 Q1	$1.9M	Hold	129,674	–	–	﹤0.01%	2169
2014 Q4	$1.9M	Buy	129,674 +17,600	+16%	+$251K	﹤0.01%	2169
2014 Q3	$1.6M	Hold	112,074	–	–	﹤0.01%	2198
2014 Q2	$1.68M	Buy	112,074 +41,800	+59%	+$504K	﹤0.01%	2215
2014 Q1	$924K	Hold	70,274	–	–	﹤0.01%	2582
2013 Q4	$577K	Hold	70,274	–	–	﹤0.01%	2857
2013 Q3	$461K	Hold	70,274	–	–	﹤0.01%	2816
2013 Q2	$432K	Buy	+70,274	New	+$363K	﹤0.01%	2745

Other funds holding AVDL

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

GJL

Gendell Jeffrey L $11.3B AUM 163.06% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $143M AUM 773.18% 1-Year Est. Return

California Public Employees Retirement System's AVDL Position: Q2 2021 in Review

California Public Employees Retirement System sold out of Avadel Pharmaceuticals (AVDL) in Q2 2021, closing a stake of 117,600 shares — an estimated $1.06M sold.

California Public Employees Retirement System first reported a position in AVDL in Q2 2013 and held it in 32 quarters. The position peaked at $3.71M in Q2 2015. 80 funds tracked by Wall St. Rank hold AVDL as of Q2 2021.

California Public Employees Retirement System reported no remaining Avadel Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
California Public Employees Retirement System sold 117,600 Avadel Pharmaceuticals shares in Q2 2021, an estimated $1.06M.
California Public Employees Retirement System first reported a position in Avadel Pharmaceuticals in Q2 2013 and held it in 32 quarters.
California Public Employees Retirement System's Avadel Pharmaceuticals position peaked at $3.71M in Q2 2015.
80 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.